SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator, KingDMC
Search This Board:
Last Post: 2/26/2015 12:31:23 PM - Followers: 380 - Board type: Free - Posts Today: 1

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
INO News: Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers 12/18/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology 12/17/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 12/15/2014 08:00:00 AM
INO News: Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bac... 10/21/2014 06:00:00 AM
INO News: Inovio Pharmaceuticals Appoints Vice President of Commercial Development 09/30/2014 07:00:00 AM
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#12790   Maybe a reversal in the works. Shorts cracity 02/26/15 12:31:23 PM
#12789   No sense in catching a falling knife. I cracity 02/24/15 02:28:59 PM
#12788   No buying interest at all: look at the ppnlf 02/24/15 01:19:25 PM
#12787   SPDR XBI Through 2/23 2,507,266 biovalidator 02/24/15 01:13:32 PM
#12786   Is there a bottom to this drop? billmick11 02/24/15 12:42:17 PM
#12785   Got some powder ready, just waiting for it cracity 02/24/15 11:20:45 AM
#12784   Inovio Pharmaceuticals Inc Analyst Rating Update nanopatent 02/20/15 04:10:25 PM
#12783   Source? pmgtrader 02/20/15 12:51:57 PM
#12782   It's a good day, Inovio secured another patent Tate 02/20/15 09:54:33 AM
#12781   Only the MM and shorts know how low Tate 02/17/15 08:59:02 AM
#12780   Very high probability bottom: 6.32. sharpei 02/13/15 07:57:35 AM
#12779   Pretty dismal chart. Looking for support levels pistol1p 02/11/15 10:57:34 PM
#12778   * * $INO Video Chart 02-11-15 * * ClayTrader 02/11/15 05:02:03 PM
#12777   Could the reason for the drop be the sbnyc 02/11/15 03:19:47 PM
#12776   This "article" is ridiculous. It just throws financial Perkin78 02/11/15 02:29:17 PM
#12775   It's more likely no news and so no ppnlf 02/11/15 02:28:02 PM
#12774   There had to be some bad news or Fsa888 02/11/15 02:10:12 PM
#12773   Nope. I sold 1/3 of my position a Perkin78 02/11/15 02:08:13 PM
#12772   When I stated that I did not think cracity 02/11/15 02:07:11 PM
#12771   INO - DNA cancer cures on the cheap. nanopatent 02/11/15 01:47:33 PM
#12770   I thought it was something new. nanopatent 02/11/15 01:46:54 PM
#12769   Anyone selling? Fsa888 02/11/15 01:43:57 PM
#12768   Breaking the support at 7 is not clever. ppnlf 02/11/15 01:21:16 PM
#12767   Short interest is big right now, and I'm cracity 02/11/15 01:05:44 PM
#12766   So are these people. cracity 02/11/15 01:04:12 PM
#12765   Is this why we are dropping like an ppnlf 02/11/15 12:54:54 PM
#12764   Board is dry but I found everyone is KingDMC 02/11/15 10:48:18 AM
#12763   I'm still holding from 3 yrs ago. I Fsa888 02/11/15 10:47:42 AM
#12762   Flipped on the way up. Taking profits and KingDMC 02/11/15 10:31:39 AM
#12761   You still holding from under $1? Fsa888 02/11/15 10:29:49 AM
#12760   Kim bought 2 million dollars worth of shares Fsa888 02/11/15 10:28:35 AM
#12759   Because I did not read the PR he KingDMC 02/11/15 10:27:54 AM
#12758   Then why are you surprised of last years news Tate 02/11/15 10:24:26 AM
#12757   Nice try? I've owned INO long since well KingDMC 02/11/15 10:23:12 AM
#12756   No that was last year. Funny nice try Tate 02/11/15 10:22:31 AM
#12755   Wow R/S?? KingDMC 02/11/15 10:07:07 AM
#12754   Form 8-K cracity 02/11/15 09:45:23 AM
#12753   R/S? What, when, where, why? nanopatent 02/11/15 09:06:56 AM
#12752   Decent volume today compared to the last few pistol1p 02/10/15 11:05:32 PM
#12751   Don't let Dr. Kim fool you R/S was cracity 02/10/15 05:08:09 PM
#12750   * * $INO Video Chart 02-10-15 * * ClayTrader 02/10/15 05:06:10 PM
#12749   No news = no support. PPS will find its ppnlf 02/10/15 10:38:27 AM
#12748   Unreal, the r/s makes this go down so Fsa888 02/10/15 09:57:29 AM
#12747   I'm not sure. I can see this drifting cracity 02/10/15 07:33:26 AM
#12746   Be good idea to pick more up on harry crumb 02/09/15 02:33:41 PM
#12745   Yes it can! This stock we hav seen harry crumb 02/09/15 02:32:41 PM
#12744   Next mini spike I am out. Things do cracity 02/09/15 02:21:39 PM
#12743   Thanks for the laugh. cracity 02/09/15 02:20:44 PM
#12742   Inovio Pharmaceuticals Inc Receives Average Target Price of $22.2 nanopatent 02/04/15 10:04:54 PM
#12741 cracity 02/04/15 04:18:54 PM